期刊文献+

eIF4E与磷酸化eIF4E结合蛋白1在甲状腺乳头状癌中的表达及意义 被引量:4

Expression of eIF4E and Phosphorylated eIF4E Binding Protein 1 in Papillary Thyroid Carcinoma
下载PDF
导出
摘要 目的观察真核细胞翻译起始因子4E(eIF4E)及磷酸化eIF4E结合蛋白1(p-4EBP1)在甲状腺乳头状癌组织中的表达,并探讨其与甲状腺乳头状癌的侵袭、转移等临床病理特征间的关系。方法采用免疫组化EnVinsion法检测66例乳头状癌(经典型乳头状癌37例,滤泡型乳头状癌29例)、20例结节性甲状腺肿伴乳头状增生及上述病例的肿瘤旁正常甲状腺组织中eIF4E与p-4EBP1的表达。结果在肿瘤旁正常甲状腺组织、甲状腺肿伴乳头状增生及乳头状癌中,eIF4E的阳性率分别为11.6%(10/86)、50.0%(10/20)和84.8%(56/66)(P<0.01);p-4EBP1的阳性率分别为8.1%(7/86)、40.0%(8/20)和66.7%(44/66)(P<0.01),并且p-4EBP1在滤泡型乳头状癌中的表达显著高于其在经典型乳头状癌中的表达(P<0.01)。eIF4E在有腺外侵袭和淋巴结转移的病例中的阳性率分别为96.7%(29/30)和100.0%(29/29),分别高于无腺外侵袭和无淋巴结转移的病例,后者阳性率分别为75.0%(27/36)和73.0%(27/37)(P<0.05)。而p-4EBP1在这两组病例中的表达差异则无显著性意义(P>0.05)。结论和正常甲状腺及甲状腺良性病变相比,eIF4E和p-4EBP1在乳头状癌中存在过表达;eIF4E的过表达与乳头状癌的侵袭与转移关系密切,在乳头状癌的进展中可能发挥了重要作用。 Objective To evaluate the expression of eukaryotic initiation factor 4E(eIF4E) and phosphorylated eIF4E binding protein 1(p-4EBP1) in papillary thyroid carcinoma(PTC) and its association with the clinicopathologic properties such as invasion and metastasis of PTC.Methods Immunohistochemistry was performed in a series of formalin-fixed,paraffin-embedded tissues including 66 cases of PTC(37 cases of conventional PTC and 29 cases of follicular variant of PTC),20 cases of nodular goiter with papillary hyperplasia(NGPH) and corresponding normal thyroid tissues(NTT) adjacent to the tumors.Results The positive rates of eIF4E in NTT,NGPH and PTC were 11.6%(10/86),50.0%(10/20) and 84.8%(56/66) respectively(P<0.01),and those of p-4EBP1 were 8.1%(7/86),40.0%(8/20) and 66.7%(44/66) respectively.Furthermore,the positive rate of p-4EBP1 in folluliar variant of PTC was significantly higher than that in conventional PTC(P<(0.01).) The eIF4E expression level was significantly higher in both extrathyroidal invasion group and lymph node metastasis group than that in intrathyroidal invasion group and non-lymph node metastasis group(P<0.05).The expression of p-4EBP1 had no significant difference among these groups(P>0.05).Conclusion eIF4E and p-4EBP1 were overexpressed in PTC compared with normal tissue and papillary hyperplasia of thyroid.eIF4E may play an important role in the progression of papillary thyroid carcinoma.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第6期764-767,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 甲状腺肿瘤 乳头状 真核细胞翻译起始因子4E 真核细胞翻译起始因子4E结合蛋白1 thyroid neoplasm,papillary eukaryotic initiation factor 4E eIF4E binding protein 1
  • 相关文献

参考文献9

  • 1[1]RHOADS R E.Regulation of eukaryotic protein synthesis by initiation factors[J].J Biol Chem,1993,268 (5):3017-3021. 被引量:1
  • 2[2]GINGRAS A C,RAUGHT B,SONENBERG N.Regulation of translation initiation by FRAP/mTOR[J].Genes Dev,2001,15(7):807-826. 被引量:1
  • 3[3]LIVOLSI V,MAZZAFERRI E,SCHNEIDER A,et al.Papillary carcinom[M]//Ronald A,Ricardo V,Philip U.Pathology and genetics of tumors of endocrine organs.Lyon:IARC Press,2004:57-66. 被引量:1
  • 4[4]LEE J W,CHOI J J,LEE K M,et al.eIF4E expression is associated with histopathologic grades in cervical neoplasia[J].Hum Pathol,2005,36(11):1197-1203. 被引量:1
  • 5[5]DE BENEDETTI A,GRAFF J R.eIF4E expression and its role in malignancies and metastases[J] Oncogene,2004,23(18):3189-3199. 被引量:1
  • 6[6]WANG S,LLOYD R V,HUTZLER M J,et al.Expression of eukaryotic translation initiation factors 4E and alpha correlates with the progression of thyroid carcinoma[J].Thyroid,2001,11 (12):1101-1107. 被引量:1
  • 7[7]KEREKATTE V,SMILEY K,HU B,et al.The proto-oncogene/translation factor eIF4E:a survey of its expression in breast carcinomas[J].Int J Cancer,1995,64(1):27-31. 被引量:1
  • 8[8]CREW J P,FUGGLE S,BICKNELL R,et al.Eukaryotic initiation factor 4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumor progression[J].Br J Cancer,2000,82(1):161-166. 被引量:1
  • 9[9]HUANG S,BJORNSTI M A,HOUGHTON P J.Rapamycins:mechanism of action and cellular resistance[J].Cancer Biol Ther,2003,2(3):222-232. 被引量:1

同被引文献42

  • 1傅云峰,谢幸,叶大风.卵巢癌细胞耐药机制及其对策研究进展[J].国外医学(妇产科学分册),2005,32(4):229-232. 被引量:5
  • 2Mozzetti S,Ferlini C,Concolino P,et al.Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients[J].Clin Cancer Res,2005,11(1):298-305. 被引量:1
  • 3Kennedy RD,Quinn JE,Mullan PB,et al.The role of BRCA1 in the cellular response to chemotherapy[J].J Natl Cancer Inst,2004,96(22):1659-1668. 被引量:1
  • 4Tarapore P,Fukasawa K.Loss of p53 and centrosome hyperamplification[J].Oncogene,2002,21(40):6234-6240. 被引量:1
  • 5Kramer A,Lukas J,Bartek J.Checking out the centrosome[J].CELLCYCLE,2004,3(11):1390-1393. 被引量:1
  • 6Kin R,Emi M,Tanabe K,et al.Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy[J].Cancer,2004,101(11):2491-2502. 被引量:1
  • 7Mazieres J,Pradines A,Favie G,et al.Perspetcives on famesyl transferase inhibitors in cancer therapy[J].Cancer Lett,2004,206(2):159-167. 被引量:1
  • 8Rojo F,Najere L,ECT AL.4E-binding protein 1,a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis[J].Clin Cancer Res,2007,13(1):81-89. 被引量:1
  • 9Huang S,Bjornstim A,Hou GJ.Rapamycins:mechanism of action and cellular resistance[J].Cancer Biol Ther,2003,2 (3):222-232. 被引量:1
  • 10Castellvi J,Carcia A.Phosphoeylated 4E binding protein 1:a hallmark of cell signaling that correlates with sevical in ovarian cancer[J].Canxer,2006,107(8):1801-1811. 被引量:1

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部